News
You can see the future first in San Francisco. Over the past year, the talk of the town has shifted from $10 billion compute ...
Luigi Naldini and Franco Locatelli. In this insightful interview, leading experts in gene therapy, Franco Locatelli ...
4d
PCQuest on MSNLooka Review: A Smart Logo Tool—But Is It Worth It?We test this AI logo maker to see if Artificial Intelligence can out-design humans. Real reviews, Looka logo design & brand ...
Canada has a remarkable claim to fame in the realm of artificial intelligence. While the United States and China dominate the ...
Hey [enter AI assistant name here], can you book me a table at the nearest good tapas restaurant next week, and invite ...
First pediatric patient shows encouraging early safety profile and meaningful improvement in visual function at one monthA second pediatric ...
Healthbeat on MSN3d
Reports of ‘Disease X’? Here’s how to think clearly when you hear about an outbreakIn a world where information travels far faster than infections, it is more important than ever to think critically about ...
ArtBlood, a biotechnology company specializing in transfusion blood production, announced that it has signed a Memorandum of Understanding (MOU) with Expression Manufacturing LLC ("Expression"), the ...
Thanks to This Silent Algorithm Imagine living in Cape Town or Johannesburg, working your regular job, and suddenly ...
You can use mobile devices to access live video surveillance. You can sign up for Vector Security by calling to schedule an appointment or by ordering online. A Vector Security representative will ...
1d
Pharmaceutical Technology on MSNNMPA approves BBM and Takeda China’s haemophilia B therapyBelief BioMed (BBM) and Takeda China have announced the receipt of China’s NMPA approval for BBM-H901for treating haemophilia ...
Genflow Biosciences Launches New Ophthalmology Development ProgramSigns MTA with Leading Ophthalmology Company LONDON, UK / ACCESS Newswire / April 10, 2025 / Genflow Biosciences Plc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results